Yoon Yeo, Ph.D. - Publications

2003 Purdue University, West Lafayette, IN, United States 

67 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Taha MS, Cresswell GM, Park J, Lee W, Ratliff TL, Yeo Y. Sustained delivery of carfilzomib by tannic acid-based nanocapsules helps develop antitumor immunity. Nano Letters. PMID 31657935 DOI: 10.1021/acs.nanolett.9b04147  0.4
2019 Park S, Hwang D, Yeo YS, Kim H, Kang J. CONFIGURE: A pipeline for identifying context specific regulatory modules from gene expression data and its application to breast cancer. Bmc Medical Genomics. 12: 97. PMID 31296219 DOI: 10.1186/s12920-019-0515-6  0.32
2019 Park S, Hwang D, Yeo YS, Kim H, Kang J. CONFIGURE: A pipeline for identifying context specific regulatory modules from gene expression data and its application to breast cancer. Bmc Medical Genomics. 12: 97. PMID 31296219 DOI: 10.1186/s12920-019-0515-6  0.32
2019 Wang J, Meng F, Kim BK, Ke X, Yeo Y. In-vitro and in-vivo difference in gene delivery by lithocholic acid-polyethyleneimine conjugate. Biomaterials. 217: 119296. PMID 31254934 DOI: 10.1016/j.biomaterials.2019.119296  0.32
2019 Tamam H, Park J, Gadalla HH, Masters AR, Abdel-Aleem JA, Abdelrahman SI, Abdelrahman AA, Lyle LT, Yeo Y. Development of liposomal gemcitabine with high drug loading capacity. Molecular Pharmaceutics. PMID 31136710 DOI: 10.1021/acs.molpharmaceut.8b01284  0.4
2019 Park JE, Park J, Jun Y, Oh Y, Ryoo G, Jeong YS, Gadalla HH, Min JS, Jo JH, Song MG, Kang KW, Bae SK, Yeo Y, Lee W. Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30954620 DOI: 10.1016/j.jconrel.2019.04.006  0.4
2019 Park J, Park J, Castanares MA, Collins DS, Yeo Y. Magnetophoretic delivery of a tumor priming agent for chemotherapy of metastatic murine breast cancer. Molecular Pharmaceutics. PMID 30916974 DOI: 10.1021/acs.molpharmaceut.8b01148  0.4
2018 Hyun H, Park J, Willis K, Park JE, Lyle LT, Lee W, Yeo Y. Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors. Biomaterials. 180: 206-224. PMID 30048910 DOI: 10.1016/j.biomaterials.2018.07.024  0.4
2018 Yuk SA, Sanchez-Rodriguez DA, Tsifansky MD, Yeo Y. Recent advances in nanomedicine for sepsis treatment. Therapeutic Delivery. 9: 435-450. PMID 29722636 DOI: 10.4155/tde-2018-0009  0.36
2018 Park J, Park JE, Hedrick VE, Wood KV, Bonham C, Lee W, Yeo Y. A Comparative In Vivo Study of Albumin-Coated Paclitaxel Nanocrystals and Abraxane. Small (Weinheim An Der Bergstrasse, Germany). e1703670. PMID 29570231 DOI: 10.1002/smll.201703670  0.4
2018 Gad SF, Park J, Park JE, Fetih GN, Tous SS, Lee W, Yeo Y. Enhancing docetaxel delivery to multidrug-resistant cancer cells with albumin-coated nanocrystals. Molecular Pharmaceutics. PMID 29341617 DOI: 10.1021/acs.molpharmaceut.7b00783  0.4
2017 Kim BK, Kim D, Kwak G, Yhee JY, Kwon IC, Kim SH, Yeo Y. Polyethylenimine-dermatan sulfate complex, a bioactive biomaterial with unique toxicity to CD146-positive cancer cells. Acs Biomaterials Science & Engineering. 3: 990-999. PMID 29457127 DOI: 10.1021/acsbiomaterials.7b00207  0.32
2017 Hyun H, Hashimoto-Hill S, Kim M, Tsifansky MD, Kim CH, Yeo Y. Succinylated chitosan derivative has local protective effects on intestinal inflammation. Acs Biomaterials Science & Engineering. 3: 1853-1860. PMID 29450257 DOI: 10.1021/acsbiomaterials.7b00262  0.36
2017 Appelbe OK, Kim BK, Rymut N, Wang J, Kron SJ, Yeo Y. Radiation-enhanced delivery of plasmid DNA to tumors utilizing a novel PEI polyplex. Cancer Gene Therapy. PMID 29255216 DOI: 10.1038/s41417-017-0004-z  0.32
2017 Park J, Pei Y, Hyun H, Castanares MA, Collins DS, Yeo Y. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 29111150 DOI: 10.1016/j.jconrel.2017.10.037  0.4
2017 Kwak G, Kim D, Nam GH, Wang SY, Kim IS, Kim SH, Kwon IC, Yeo Y. Programmed Cell Death Protein Ligand-1 (PD-L1) Silencing with Polyethylenimine-Dermatan Sulfate Complex for Dual Inhibition of Melanoma Growth. Acs Nano. PMID 28985469 DOI: 10.1021/acsnano.7b04717  0.32
2017 Han N, Xu J, Pang L, Hyun H, Park J, Yeo Y. Development of surface-variable polymeric nanoparticles for drug delivery to tumors. Molecular Pharmaceutics. PMID 28368124 DOI: 10.1021/acs.molpharmaceut.7b00050  0.4
2016 Abouelmagd SA, Meng F, Kim BK, Hyun H, Yeo Y. Tannic acid-mediated surface functionalization of polymeric nanoparticles. Acs Biomaterials Science & Engineering. 2: 2294-2303. PMID 28944286 DOI: 10.1021/acsbiomaterials.6b00497  0.32
2016 Yang WK, Lee CH, Kim MH, Kim SH, Choi HY, Yeo Y, Park YC. Effects of Inhalable Microparticles of Seonpyejeongcheon-Tang in an Asthma Mouse Model: - Effects of Microparticles of SJT. Journal of Pharmacopuncture. 19: 303-311. PMID 28097040 DOI: 10.3831/KPI.2016.19.031  0.32
2016 Park J, Sun B, Yeo Y. Albumin-coated nanocrystals for carrier-free delivery of paclitaxel. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28049022 DOI: 10.1016/j.jconrel.2016.12.040  0.4
2016 Cho EJ, Doh KO, Park J, Hyun H, Wilson EM, Snyder PW, Tsifansky MD, Yeo Y. Zwitterionic chitosan for the systemic treatment of sepsis. Scientific Reports. 6: 29739. PMID 27412050 DOI: 10.1038/srep29739  1
2016 Park J, Kadasala NR, Abouelmagd SA, Castanares MA, Collins DS, Wei A, Yeo Y. Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery. Biomaterials. 101: 285-295. PMID 27310916 DOI: 10.1016/j.biomaterials.2016.06.007  1
2016 Park B, Park S, Shin HR, Shin A, Yeo Y, Choi JY, Jung KW, Kim BG, Kim YM, Noh DY, Ahn SH, Kim JW, Kang S, Kim JH, Kim TJ, et al. Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea. Bmc Cancer. 16: 5. PMID 26732868 DOI: 10.1186/s12885-015-2040-0  0.32
2016 Yeo Y, Park J, Roh S, Levkoff S. Use of electronic personal health records (PHRs) for complementary and alternative medicine (CAM) disclosure: Implications for integrative health care Complementary Therapies in Medicine. 26: 108-116. DOI: 10.1016/j.ctim.2016.03.008  0.4
2015 Park J, Park J, Pei Y, Xu J, Yeo Y. Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines. Advanced Drug Delivery Reviews. PMID 26686832 DOI: 10.1016/j.addr.2015.12.004  1
2015 Pei Y, Yeo Y. Drug delivery to macrophages: Challenges and opportunities. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26686082 DOI: 10.1016/j.jconrel.2015.12.014  1
2015 Abouelmagd SA, Ku YJ, Yeo Y. Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel. Journal of Drug Targeting. 23: 725-35. PMID 26453168 DOI: 10.3109/1061186X.2015.1054829  1
2015 Yeo Y, Jung JW, Park K, Kim ID. Graphene-Wrapped Anatase TiO2 Nanofibers as High-Rate and Long-Cycle-Life Anode Material for Sodium Ion Batteries. Scientific Reports. 5: 13862. PMID 26355340 DOI: 10.1038/srep13862  0.64
2015 Yeo Y, Kim BK. Drug Carriers: Not an Innocent Delivery Man. The Aaps Journal. PMID 26017163 DOI: 10.1208/s12248-015-9789-6  1
2015 Lee JH, Yeo Y. Controlled Drug Release from Pharmaceutical Nanocarriers. Chemical Engineering Science. 125: 75-84. PMID 25684779 DOI: 10.1016/j.ces.2014.08.046  1
2015 Abouelmagd SA, Sun B, Chang AC, Ku YJ, Yeo Y. Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right? Molecular Pharmaceutics. 12: 997-1003. PMID 25658769 DOI: 10.1021/mp500817h  1
2015 Cho EJ, Sun B, Doh KO, Wilson EM, Torregrosa-Allen S, Elzey BD, Yeo Y. Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer. Biomaterials. 37: 312-9. PMID 25453960 DOI: 10.1016/j.biomaterials.2014.10.039  1
2015 Liu T, Yang Y, Huang GB, Yeo YK, Lin Z. Driver Distraction Detection Using Semi-Supervised Machine Learning Ieee Transactions On Intelligent Transportation Systems. DOI: 10.1109/TITS.2015.2496157  0.36
2015 Min KJ, Binns M, Oh SY, Cha HY, Kim JK, Yeo YK. Screening of site-wide retrofit options for the minimization of CO2 emissions in process industries Applied Thermal Engineering. 90: 335-344. DOI: 10.1016/j.applthermaleng.2015.07.008  0.32
2015 Kim TJ, Lee KB, Baek SA, Choi J, Ha SH, Lim SH, Park SY, Yeo Y, Park SU, Kim JK. Determination of lipophilic metabolites for species discrimination and quality assessment of nine leafy vegetables Journal of the Korean Society For Applied Biological Chemistry. 58: 909-918. DOI: 10.1007/s13765-015-0119-6  0.32
2015 Park CG, Shasteen C, Amoozgar Z, Park J, Kim SN, Lee JE, Lee MJ, Suh Y, Seok HK, Yeo Y, Choy YB. Photo-crosslinkable chitosan hydrogel as a bioadhesive for esophageal stents Macromolecular Research. DOI: 10.1007/s13233-015-3115-0  1
2015 Cho HJ, Choi SH, Kim TY, Kim JK, Yeo YK. Design of a dividing wall column for fractionation of biodiesel Korean Journal of Chemical Engineering. 32: 1229-1242. DOI: 10.1007/s11814-014-0347-1  0.32
2015 Ahmed F, Cho HJ, Kim JK, Seong NU, Yeo YK. A real-time model based on least squares support vector machines and output bias update for the prediction of NO x emission from coal-fired power plant Korean Journal of Chemical Engineering. 32: 1029-1036. DOI: 10.1007/s11814-014-0301-2  0.32
2015 Hong SW, Cho HJ, Kim JK, Ahmed F, Yeo YK. A kinetic study for the noncatalytic esterification of palm fatty acid distillate International Journal of Chemical Kinetics. 47: 489-500. DOI: 10.1002/kin.20926  0.32
2014 Feng M, Ibrahim BM, Wilson EM, Doh KO, Bergman BK, Park C, Yeo Y. Stabilization of a hyaluronate-associated gene delivery system using calcium ions. Biomaterials Science. 2: 936-942. PMID 25893092 DOI: 10.1039/c4bm00012a  1
2014 Abouelmagd SA, Hyun H, Yeo Y. Extracellularly activatable nanocarriers for drug delivery to tumors. Expert Opinion On Drug Delivery. 11: 1601-18. PMID 24950343 DOI: 10.1517/17425247.2014.930434  1
2014 Park J, Brust TF, Lee HJ, Lee SC, Watts VJ, Yeo Y. Polydopamine-based simple and versatile surface modification of polymeric nano drug carriers. Acs Nano. 8: 3347-56. PMID 24628245 DOI: 10.1021/nn405809c  1
2014 Hoare T, Yeo Y, Bellas E, Bruggeman JP, Kohane DS. Prevention of peritoneal adhesions using polymeric rheological blends. Acta Biomaterialia. 10: 1187-93. PMID 24365709 DOI: 10.1016/j.actbio.2013.12.029  1
2014 Liu KC, Yeo Y. Extracellular stability of nanoparticulate drug carriers. Archives of Pharmacal Research. 37: 16-23. PMID 24214175 DOI: 10.1007/s12272-013-0286-0  1
2014 Park YC, Jin M, Kim SH, Kim MH, Namgung U, Yeo Y. Effects of inhalable microparticle of flower of Lonicera japonica in a mouse model of COPD. Journal of Ethnopharmacology. 151: 123-30. PMID 24211495 DOI: 10.1016/j.jep.2013.10.013  0.32
2013 Amoozgar Z, Park J, Lin Q, Weidle JH, Yeo Y. Development of quinic acid-conjugated nanoparticles as a drug carrier to solid tumors. Biomacromolecules. 14: 2389-95. PMID 23738975 DOI: 10.1021/bm400512g  1
2013 Yeo Y. Emerging technology in evaluation of nanomedicine. Molecular Pharmaceutics. 10: 2091-2. PMID 23725442 DOI: 10.1021/mp400264n  1
2013 Gullotti E, Park J, Yeo Y. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles. Pharmaceutical Research. 30: 1956-67. PMID 23609560 DOI: 10.1007/s11095-013-1039-y  1
2013 Liu KC, Yeo Y. Zwitterionic chitosan-polyamidoamine dendrimer complex nanoparticles as a pH-sensitive drug carrier. Molecular Pharmaceutics. 10: 1695-704. PMID 23510114 DOI: 10.1021/mp300522p  1
2013 Cho EJ, Holback H, Liu KC, Abouelmagd SA, Park J, Yeo Y. Nanoparticle characterization: state of the art, challenges, and emerging technologies. Molecular Pharmaceutics. 10: 2093-110. PMID 23461379 DOI: 10.1021/mp300697h  1
2012 Sun B, Yeo Y. Nanocrystals for the parenteral delivery of poorly water-soluble drugs. Current Opinion in Solid State & Materials Science. 16: 295-301. PMID 23645994 DOI: 10.1016/j.cossms.2012.10.004  1
2012 Doh KO, Yeo Y. Application of polysaccharides for surface modification of nanomedicines. Therapeutic Delivery. 3: 1447-56. PMID 23323561 DOI: 10.4155/tde.12.105  1
2012 Amoozgar Z, Park J, Lin Q, Yeo Y. Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery. Molecular Pharmaceutics. 9: 1262-70. PMID 22489704 DOI: 10.1021/mp2005615  1
2012 Amoozgar Z, Rickett T, Park J, Tuchek C, Shi R, Yeo Y. Semi-interpenetrating network of polyethylene glycol and photocrosslinkable chitosan as an in-situ-forming nerve adhesive. Acta Biomaterialia. 8: 1849-58. PMID 22310507 DOI: 10.1016/j.actbio.2012.01.022  1
2012 Amoozgar Z, Yeo Y. Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 4: 219-33. PMID 22231928 DOI: 10.1002/wnan.1157  1
2011 Ibrahim BM, Park S, Han B, Yeo Y. A strategy to deliver genes to cystic fibrosis lungs: a battle with environment. Journal of Controlled Release : Official Journal of the Controlled Release Society. 155: 289-95. PMID 21843562 DOI: 10.1016/j.jconrel.2011.07.039  1
2011 Ibrahim BM, Tsifansky MD, Yang Y, Yeo Y. Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease. Expert Opinion On Drug Delivery. 8: 451-66. PMID 21375469 DOI: 10.1517/17425247.2011.561310  1
2011 Rickett TA, Amoozgar Z, Tuchek CA, Park J, Yeo Y, Shi R. Rapidly photo-cross-linkable chitosan hydrogel for peripheral neurosurgeries. Biomacromolecules. 12: 57-65. PMID 21128673 DOI: 10.1021/bm101004r  1
2010 Rask F, Dallabrida SM, Ismail NS, Amoozgar Z, Yeo Y, Rupnick MA, Radisic M. Photocrosslinkable chitosan modified with angiopoietin-1 peptide, QHREDGS, promotes survival of neonatal rat heart cells. Journal of Biomedical Materials Research. Part A. 95: 105-17. PMID 20540095 DOI: 10.1002/jbm.a.32808  1
2010 Ibrahim BM, Jun SW, Lee MY, Kang SH, Yeo Y. Development of inhalable dry powder formulation of basic fibroblast growth factor. International Journal of Pharmaceutics. 385: 66-72. PMID 19853028 DOI: 10.1016/j.ijpharm.2009.10.029  1
2008 Snider C, Lee SY, Yeo Y, Grégori GJ, Robinson JP, Park K. Microenvironment-controlled encapsulation (MiCE) process: effects of PLGA concentration, flow rate, and collection method on microcapsule size and morphology. Pharmaceutical Research. 25: 5-15. PMID 17914663 DOI: 10.1007/s11095-007-9456-4  1
2006 Park JH, Ye M, Yeo Y, Lee WK, Paul C, Park K. Reservoir-type microcapsules prepared by the solvent exchange method: effect of formulation parameters on microencapsulation of lysozyme. Molecular Pharmaceutics. 3: 135-43. PMID 16579642 DOI: 10.1021/mp050083w  1
2004 Yeo Y, Park K. Characterization of reservoir-type microcapsules made by the solvent exchange method. Aaps Pharmscitech. 5: e52. PMID 15760049 DOI: 10.1208/pt050452  1
2004 Yeo Y, Park K. A new microencapsulation method using an ultrasonic atomizer based on interfacial solvent exchange. Journal of Controlled Release : Official Journal of the Controlled Release Society. 100: 379-88. PMID 15567503 DOI: 10.1016/j.jconrel.2004.09.012  1
2004 Yeo Y, Chen AU, Basaran OA, Park K. Solvent exchange method: a novel microencapsulation technique using dual microdispensers. Pharmaceutical Research. 21: 1419-27. PMID 15359577 DOI: 10.1023/B:PHAM.0000036916.96307.d8  1
2004 Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Archives of Pharmacal Research. 27: 1-12. PMID 14969330  1
2003 Yeo Y, Basaran OA, Park K. A new process for making reservoir-type microcapsules using ink-jet technology and interfacial phase separation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 93: 161-73. PMID 14636722 DOI: 10.1016/j.jconrel.2003.08.021  1
Show low-probability matches.